Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Kiyoshi Itagaki, Ph.D.


This page shows the publications Kiyoshi Itagaki has written about Calcium Channel Blockers.
Connection Strength

  1. Cytoskeletal reorganization internalizes multiple transient receptor potential channels and blocks calcium entry into human neutrophils. J Immunol. 2004 Jan 01; 172(1):601-7.
    View in: PubMed
    Score: 0.217
  2. Non-specific effects of 4-chloro-m-cresol may cause calcium flux and respiratory burst in human neutrophils. Biochem Biophys Res Commun. 2005 Nov 04; 336(4):1087-95.
    View in: PubMed
    Score: 0.062
  3. Photochemical identification of transmembrane segment IVS6 as the binding region of semotiadil, a new modulator for the L-type voltage-dependent Ca2+ channel. J Biol Chem. 1998 Feb 20; 273(8):4635-41.
    View in: PubMed
    Score: 0.036
  4. Azidobutyryl clentiazem, a new photoactivatable diltiazem analog, labels benzothiazepine binding sites in the alpha 1 subunit of the skeletal muscle calcium channel. FEBS Lett. 1993 Nov 22; 334(3):261-4.
    View in: PubMed
    Score: 0.027
  5. Mechanism of action of calcium channel modulator drugs. Identification of a unique, labile, drug-binding polypeptide in a purified calcium channel preparation. Ann N Y Acad Sci. 1988; 522:176-86.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.